𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Targeting the epidermal growth factor receptor by gefitinib for treatment of hepatocellular carcinoma

✍ Scribed by Michael Höpfner; Andreas P. Sutter; Alexander Huether; Detlef Schuppan; Martin Zeitz; Hans Scherübl


Book ID
116650487
Publisher
Elsevier Science
Year
2004
Tongue
English
Weight
361 KB
Volume
41
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Targeting the epidermal growth factor re
✍ Andreas P. Sutter; Michael Höpfner; Alexander Huether; Kerstin Maaser; Hans Sche 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 370 KB 👁 1 views

## Abstract Esophageal cancer is the sixth most common cause of cancer‐related death worldwide. Because of very poor 5‐year survival new therapeutic approaches are mandatory. Erlotinib (Tarceva™), an inhibitor of epidermal growth factor receptor tyrosine kinase (EGFR‐TK), potently suppresses the gr